leukemia	is a	hematologic malignancy
leukemia	is a	disease of white blood cells
acute myeloid leukemia	is a	myeloid malignancy
acute lymphoblastic leukemia	is a	lymphoid malignancy
chronic myeloid leukemia	is a	myeloproliferative neoplasm
chronic lymphocytic leukemia	is a	lymphoid malignancy
hairy cell leukemia	is a	B-cell leukemia
Hodgkin lymphoma	is a	lymphoid malignancy
diffuse large B-cell lymphoma	is a	non-Hodgkin lymphoma
follicular lymphoma	is a	non-Hodgkin lymphoma
leukemia	may cause	anemia
leukemia	may cause	thrombocytopenia
leukemia	may cause	increased infection risk
acute myeloid leukemia	presents with	cytopenias
acute myeloid leukemia	presents with	mucosal bleeding
acute lymphoblastic leukemia	presents with	bone pain
chronic lymphocytic leukemia	presents with	lymphadenopathy
Hodgkin lymphoma	presents with	mediastinal mass
diffuse large B-cell lymphoma	presents with	rapidly enlarging mass
follicular lymphoma	presents with	painless lymphadenopathy
Hodgkin lymphoma	has	Reed-Sternberg cells
Reed-Sternberg cells	are diagnostic feature of	Hodgkin lymphoma
t(14;18) translocation	is a	chromosomal translocation
BCR-ABL1 fusion	is a	constitutively active tyrosine kinase
Philadelphia chromosome	is a	genetic abnormality
BCR-ABL1 fusion	is associated with	chronic myeloid leukemia
BCR-ABL1 testing	is used for	CML diagnosis
imatinib	is a	tyrosine kinase inhibitor
imatinib	treats	chronic myeloid leukemia
dasatinib	is a	tyrosine kinase inhibitor
dasatinib	treats	chronic myeloid leukemia
R-CHOP regimen	treats	diffuse large B-cell lymphoma
rituximab	is a	monoclonal antibody
cyclophosphamide	is a	alkylating agent
cytarabine	is a	nucleoside analog
cytarabine	treats	acute myeloid leukemia
etoposide	is a	chemotherapy agent
bone marrow transplant	is a	curative therapy
allogeneic stem cell transplant	is a	curative therapy
hematopoietic stem cell transplant	is a	curative therapy
Down syndrome	is a risk factor for	acute leukemia
age	is a risk factor for	leukemia
radiation exposure	is a risk factor for	leukemia
benzene exposure	is a risk factor for	leukemia
smoking	is a risk factor for	acute myeloid leukemia
TP53 mutation	is a prognostic factor for	leukemia
cytogenetic abnormality	is a prognostic factor for	leukemia
NPM1 mutation	is a prognostic marker for	acute myeloid leukemia
FLT3-ITD mutation	is a prognostic factor for	acute myeloid leukemia
EBV infection	is associated with	Hodgkin lymphoma
t(11;18) translocation	is a genetic abnormality in	MALT lymphoma
t(14;18) translocation	is associated with	follicular lymphoma
Reed-Sternberg cells	are diagnostic feature of	Hodgkin lymphoma
Rituximab	is a	monoclonal antibody
follicular lymphoma	treated with	rituximab
diffuse large B-cell lymphoma	treated with	rituximab
hairy cell leukemia	treated with	cladribine
cladribine	is a	purine analog
pentostatin	is a	purine analog
pentostatin	treats	hairy cell leukemia
bone marrow biopsy	is a	diagnostic test for leukemia
flow cytometry	is a	diagnostic test for leukemia
cytogenetic analysis	is a	diagnostic test for leukemia
molecular testing	is a	diagnostic test for leukemia
minimal residual disease	is an	outcome measure
complete remission	is an	treatment outcome
partial remission	is an	treatment outcome
disease-free survival	is an	outcome measure
overall survival	is an	outcome measure
neutropenia	is a	leukocyte deficiency
neutropenia	increases	infection risk
lymphocytosis	is a	high lymphocyte count
leukocytosis	is a	high white blood cell count
thrombocytopenia	is a	cytopenia
cytopenias	are a	hallmark of leukemia
granulocyte colony-stimulating factor	is a	supportive therapy
granulocyte colony-stimulating factor	is used for	neutropenia
CAR T-cell therapy	is a	treatment modality
axicabtagene ciloleucel	is a	CAR T-cell therapy
CD19	is a	B-cell marker
CD20	is a	B-cell marker
rituximab	targets	CD20
BCR-ABL1	is a	fusion gene
CML	has	BCR-ABL1 fusion
R-CHOP regimen	includes	rituximab
Hodgkin lymphoma	responsive to	ABVD regimen
ABVD regimen	is a	chemotherapy regimen
Burkitt lymphoma	is a	non-Hodgkin lymphoma
HIV infection	is a risk factor for	certain non-Hodgkin lymphomas
BCL2 overexpression	is a	feature of follicular lymphoma
t(15;17) translocation	is a genetic abnormality in	acute promyelocytic leukemia
APL	is a subtype of	AML
all-trans retinoic acid	is a	differentiation agent
all-trans retinoic acid	treats	acute promyelocytic leukemia
acute promyelocytic leukemia	is a	subtype of AML
AML-M3	is a	AML subtype
Chronic lymphocytic leukemia	may progress to	Richter transformation
Richter transformation	is a	progression of CLL
Mantle cell lymphoma	is a	non-Hodgkin lymphoma
Sepsis	is a	complication of chemotherapy
